Related Experiment Video
Updated: Aug 19, 2026
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Successful living-related liver transplantation for familial hypercholesterolemia in the Middle East
Mohamad Khalifeh1, Walid Faraj, Nigel Heaton
1Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
Insights
Familial hypercholesterolemia (FH), a genetic disorder causing high cholesterol, can be effectively treated with liver transplantation. This paper details the first living-related liver transplant (LRLT) for FH, offering a new treatment option.
Area of Science:
- Genetics and Metabolic Disorders
- Cardiovascular Medicine
- Transplantation Surgery
Background:
- Familial hypercholesterolemia (FH) is an autosomal dominant inherited metabolic disorder.
- It leads to advanced vascular atherosclerosis and premature death, primarily from coronary artery disease.
- The genetic defect involves the LDL receptor gene on chromosome 19.
Observation:
- Liver transplantation is the most effective treatment for FH.
- Living-related liver transplantation (LRLT) is a viable option for children with inherited metabolic diseases.
- This paper presents the first case of LRLT for familial hypercholesterolemia.
Findings:
- Successful LRLT for FH demonstrates its efficacy in managing this severe genetic condition.
- The procedure addresses the underlying metabolic defect causing hypercholesterolemia.
- This case highlights LRLT as a critical therapeutic strategy for FH.
Implications:
- LRLT offers a life-saving treatment for pediatric FH patients.
- This approach may improve long-term outcomes and reduce premature mortality associated with FH.
- Further research into LRLT for FH could expand treatment paradigms for inherited metabolic disorders.
Abstract:
Familial hypercholesterolemia (FH) is an autosomal dominant inherited metabolic disorder resulting in advanced vascular atherosclerosis and premature death, primarily from coronary artery disease. The primary defect is a mutation in the gene encoding for the plasma LDL receptor located on the short arm of chromosome 19. Liver transplantation is currently the most effective method of treating this disorder. Living-related liver transplantation (LRLT) has become an excellent modality for treating children, including those with inherited metabolic diseases. In this paper, we describe the first report of a LRLT for familial hypercholesterolemia and review FH and the role of liver transplantation.
